Van Eck Associates Corp Ginkgo Bioworks Holdings, Inc. Transaction History

Van Eck Associates Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$1.06 - $1.67 $1,875 - $2,954	1,769 Added 7.45%	25,506 $29,000
Q4 2023 Feb 05, 2024	BUY	$1.26 - $1.79 $5,475 - $7,779	4,346 Added 22.41%	23,737 $40,000
Q2 2023 Aug 03, 2023	BUY	$1.14 - $1.95 $11,840 - $20,252	10,386 Added 115.34%	19,391 $36,000
Q1 2023 May 03, 2023	SELL	$1.2 - $2.19 $7,473 - $13,639	-6,228 Reduced 40.88%	9,005 $12,000
Q4 2022 Feb 08, 2023	BUY	$1.63 - $3.52 $4,063 - $8,775	2,493 Added 19.57%	15,233 $26,000
Q3 2022 Oct 27, 2022	BUY	$0.73 - $3.74 $4,753 - $24,354	6,512 Added 104.56%	12,740 $39,000
Q2 2022 Aug 03, 2022	BUY	$2.2 - $4.2 $4,567 - $8,719	2,076 Added 50.0%	6,228 $15,000
Q4 2021 Jan 26, 2022	BUY	$8.31 - $14.92 $34,503 - $61,947	4,152 New	4,152 $35,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

Stay updated on Van Eck Associates Corp with notifications on news.